Skip to content

Heparin Cap, Injection Cap Male Luer-

by Linton Biomed Corp.

510(k) K841772

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK841772 Date6 Jul 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
FPA
Device Class
Class II
Regulation
21 CFR Part 880.5440
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a heparin cap, specifically an injection cap with a male Luer connector. It is designed to be attached to intravenous lines or catheters to maintain patency and prevent clotting by delivering heparinized solution.

The device is supplied as a single-use component and is intended for use in general hospital settings. It received FDA 510(k) clearance (K841772) on July 6, 1984, and is classified under product code FPA. No information is provided regarding sterility, MRI safety, sizes, or storage conditions.

Other devices from Linton Biomed Corp.

Questions

AI-generated answers, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the HEPARIN CAP used for?

    The HEPARIN CAP is an injection cap with a male Luer connector designed to attach to intravenous lines or catheters to maintain patency and prevent clotting by delivering heparinized solution.

  • Is the HEPARIN CAP supplied sterile or non-sterile?

    The device data does not provide information regarding sterility, so it cannot be confirmed whether the HEPARIN CAP is supplied sterile or non-sterile based on the available details.

  • Is the HEPARIN CAP intended for single-use or reuse?

    The HEPARIN CAP is supplied as a single-use component, meaning it is intended for one-time use and should not be reused after initial application.

  • What regulatory pathway was used for the HEPARIN CAP?

    The HEPARIN CAP received FDA 510(k) clearance (K841772) on July 6, 1984, indicating it was cleared through the traditional 510(k) pathway as substantially equivalent to a predicate device.

  • Are there different sizes or models of the HEPARIN CAP available?

    The device data does not specify any sizes, models, or reference numbers for the HEPARIN CAP, so no variations in size or model can be determined from the provided information.